Frontida BioPharm, INC.

2021 Quarterly Newsletter

BLISTER PACKAGING LINE

Frontida is pleased to offer our top-tier blister packaging line. Our blister packaging line is capable of packaging oral tablets and capsules, secondary packaging, and assembly of pharmaceuticals and medical devices + kits. Some of the features include:
  • High-Speed IMA Giant A86 Line with Inline Cartoning, Bundling, Case Packing & Pallet Loading
  • Multi-product feeding system at high speeds & accuracy
  • Quick single operator changeover and small-batch capability
  • Auto leaflet and booklet inserting
  • Visions systems for lot & expiration verifications
  • Thermo and cold forming options
  • Forming Materials: PP, PVC, PVC/PVDC, PVC/Aclar, PET, COC and others
  • Lidding Materials: Alu-Hard, Alu Soft, Alu/Paper, Alu/Polyester, PP and others
For more information on our blister packaging services, contact us here:
https://frontidabiopharm.com/contact-us/

Abuse-Deterrent Services

On January 13th, 2021, Frontida launched its new Category 1 (CAT.one™) in vitro testing and evaluation services to support the development and regulatory approvals for abuse-deterrent formulations of pain management and central nervous system (CNS) targeted therapies.
Frontida has also acquired specialized product manipulation equipment uniquely designed to simulate various abuse techniques (such as chewing, smoking and vaping) essential to reproducibly performing Category 1 evaluations.

WELCOME MANUEL & BOB!

Frontida welcomes Manuel Valdés, Ph.D. and Bob Steitz, our latest Directors of Business Development. Manuel Valdés joins Frontida with over 15 years of diverse biotech expertise. Throughout his career, Manuel has amassed extensive experience with genetics and genomics, capital equipment sales, gene editing services and commercial manufacturing of API drug products.

Joining Manuel is Bob Steitz, Director of Business Development. Bob has over 15 years of extensive experience working in the biotech and pharmaceutical industries. Bob has worked with several reputable CDMOs and has gained valuable knowledge throughout his professional career in contract chemical development, formulation development and stability services.

At Frontida, Manuel & Bob will support customers and help meet their needs with Frontida’s capabilities by supporting pharmaceutical companies in the development, scale-up and commercial manufacturing of immediate and controlled-release oral solid dose, powder and liquid products; ensuring robust product performance and on-time supply of clinical trial materials and commercial products.
Contact us to learn more about our drug development and formulation services. Our highly motivated team is ready to take on your drug development concepts and bring them to the commercial market. To learn more, reach out at BD@frontidabiopharm.com.